SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

AMC Robotics Corp. engages in developing and deploying AI-enabled robotics and smart security solutions, especially for warehouse automation, enterprise security, robotics patrol/incident-response and logistics automation. The company is headquartered in New York, NY.

AMC Robotics Corp.

AMCI is trending as traders discuss its potential for a short squeeze and speculate on price movements, with some expressing concerns about it being a pump and dump. The stock's low float and recent volatility are key points of discussion, with community members comparing it to other robotics plays. Some traders are also eyeing related tickers, anticipating similar potential moves.

Radiopharm Theranostics Ltd. operates as a pre-clinical and clinical research company. It focuses on the development of radiopharmaceutical products for diagnostic and therapeutic uses in areas of high unmet medical need. The company is founded by Paul A. Hopper in 2021 headquartered Carlton, Australia.

Radiopharm Theranostics Ltd - ADR

RADX is trending due to discussions around a potential short squeeze and high volatility, fueled by the company's recent activity and a relatively small float. Community members are debating fair value and if it is worth accumulating, and some traders are highlighting technical indicators. The company is a clinical-stage biopharmaceutical firm focused on developing innovative oncology radiopharmaceuticals.

ARB IOT Group Ltd. is a holding company that engages in the provision of solutions for the integration of IoT systems and devices. It operates through the Internet of Things and Investment Holding and Others segments. The company was founded on March 1, 2022 and is headquartered in Singapore.

ARB IOT Group Ltd

ARBB is trending due to community members discussing a potential short squeeze driven by the stock's low float. Traders are actively monitoring key price levels, anticipating a run to higher prices, with some comparing it to previous runners. Intense volatility has led to multiple trading halts, adding to the speculative buzz.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray is trending amid speculation surrounding potential marijuana rescheduling, driven by rumors of an upcoming announcement and a possible executive order. Community discussions revolve around the potential impact on the cannabis sector, tax implications, and Tilray's future market position, with some traders anticipating a significant short squeeze if the rescheduling occurs.

Greenwich LifeSciences, Inc. engages in the development of a breast cancer immunotherapy designed to prevent the recurrence of breast cancer following surgery. The company was founded by Eric Rothe on August 29, 2006 and is headquartered in Stafford, TX.

Greenwich LifeSciences Inc

Greenwich LifeSciences is trending as the community discusses the potential for a short squeeze and the impact of preliminary data showing an 80% reduction in breast cancer recurrence rates. Community members are debating the significance of the news, speculating about a potential buyout, and analyzing short interest data. The stock is seen as a biotech microcap with a history of explosive moves, making it a high-risk, high-reward play.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending, fueled by Wedbush's reaffirmed bullish outlook and robotaxi optimism, despite concerns about valuation and declining EV sales; the community is buzzing about the potential for new all-time highs and debates the impact of AI and SpaceX on the stock, with both bulls and bears digging in.

ServiceNow, Inc. engages in the provision of an end-to-end workflow automation platform for digital businesses. Its Now Platform is a cloud-based solution embedded with artificial intelligence (AI) and machine learning (ML). The company was founded by Frederic B. Luddy in June 2004 and is headquartered in Santa Clara, CA.

ServiceNow Inc

ServiceNow's stock is trending amid reports of a potential acquisition of cybersecurity firm Armis, sparking debate about the deal's price tag and strategic fit. While some investors are wary of the cost and integration risks, analysts remain optimistic about the long-term upside of strengthening ServiceNow's platform with cybersecurity capabilities. The community is weighing the short-term volatility against the potential for long-term gains in the cybersecurity space.

Artiva Biotherapeutics, Inc. operates as a biotechnology company for the treatment of hematologic cancers. It offers NK cell therapies for cancer. The company was founded by Thomas J. Farrell in 2019 and is headquartered in San Diego, CA.

Artiva Biotherapeutics Inc

ARTV is trending after receiving FDA Fast Track designation for its AlloNK therapy in refractory rheumatoid arthritis, a significant step for its clinical development. The community is discussing the potential impact on the autoimmune market and the possibility of future data readouts and clinical responses. Bullish sentiment is fueled by analyst upgrades and price target increases, though some caution against potential dilution and profit-taking.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is trending downwards, sparking debates about its viability and potential for a delisting pump. Community members are expressing frustration with its performance relative to Bitcoin and other altcoins, with some labeling it a scam due to perceived lack of utility and the performance of the Janction token. Despite the negative sentiment, some bulls remain hopeful, citing ongoing development, partnerships, and the potential for a turnaround in 2026.

Broadcom Inc. is a global technology company, which designs, develops, and supplies semiconductors and infrastructure software solutions. It operates through the Semiconductor Solutions and Infrastructure Software segments. The Semiconductor Solutions segment refers to product lines and intellectual property licensing. The Infrastructure Software segment relates to mainframe, distributed and cyber security solutions, and the FC SAN business. The company was founded in 1961 and is headquartered in Palo Alto, CA.

Broadcom Inc

AVGO is trending downwards as investors express concern over potential margin compression despite strong AI-driven revenue growth and a large order backlog. The community is debating whether this dip is a buying opportunity or a sign of broader tech sector vulnerability, with some pointing to analysts' price target increases as a reason for optimism. Discussions also include comparing AVGO's valuation to other tech giants like META and the potential impact of AI infrastructure spending.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

DXCM CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. Shareholders of Securities Fraud Class Action Lawsuit

DXCM CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. Shareholders of Securities Fraud Class Action Lawsuit DXCM CLASS ACTION ALERT: Kessler Topaz Meltzer & Check, LLP...

Castleark Management LLC Invests $27.18 Million in DexCom, Inc. $DXCM

Castleark Management LLC bought a new stake in shares of DexCom, Inc. (NASDAQ:DXCM - Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities...

Bellevue Group AG Cuts Holdings in DexCom, Inc. $DXCM

Bellevue Group AG lowered its position in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 19.1% during the second quarter, according to its most recent disclosure with the Securities and Exchange...

DexCom, Inc. Investors Reminder: Kessler Topaz Meltzer & Check, LLP Reminds DexCom, Inc. Shareholders of Deadline in Securities Fraud Class Action Lawsuit

The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against DexCom, Inc. (DexCom) (NASDAQ: DXCM) on behalf of...

Class Action Filed Against DexCom, Inc. (DXCM) - December 26, 2025 Deadline to Join - Contact Levi & Korsinsky

Class Action Filed Against DexCom, Inc. (DXCM) - December 26, 2025 Deadline to Join - Contact Levi & Korsinsky Class Action Filed Against DexCom, Inc. (DXCM) - December 26, 2025 Deadline to Join...

Lightning Round: MercadoLibre is 'such a good company', says Jim Cramer

'Mad Money' host Jim Cramer weighs in on stocks including: MercadoLibre, NRGEnergy, AST SpaceMobile, Dexcom, and Bank of Nova Scotia...

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM

The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of December 26, 2025 in DexCom, Inc. Lawsuit - DXCM The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of...

Frontier Capital Management Co. LLC Sells 35,907 Shares of DexCom, Inc. $DXCM

Frontier Capital Management Co. LLC cut its stake in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 3.7% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and...

Sirios Capital Management L P Boosts Stock Position in DexCom, Inc. $DXCM

Sirios Capital Management L P increased its stake in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 17.2% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The...

Natixis Has $5.47 Million Holdings in DexCom, Inc. $DXCM

Natixis raised its position in DexCom, Inc. (NASDAQ:DXCM - Free Report) by 217.5% during the second quarter, according to its most recent filing with the SEC. The firm owned 62,713 shares of the...

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Current Price	$66.22
Prev Close	$66.96
Open	$67.41
Dividend Yield	0.00%
50-Day Moving Average	$64.10
Beta	0.82
Avg. Volume	7.6M
PE Ratio	37.27

52-Week High	$93.25
52-Week Low	$54.11
Market Capitalization	$26.18B
EPS (Annual)	$1.42
Price to Book	9.58
Revenue Per Employee	$391,553.40
Enterprise Value/EBITDA	N/A

DXCM
Dexcom Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DXCM News

DXCMDexcom Inc